Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - eplerenone, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; iron oxide red; lactose monohydrate; titanium dioxide; sodium lauryl sulfate; magnesium stearate; hypromellose; macrogol 400; polysorbate 80; iron oxide yellow; purified talc; croscarmellose sodium - eplerenone is indicated: - to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3-14 days of an acute myocardial infarction (see clinical trials and dosage and administration). ; - to reduce the risk of cardiovascular mortality and morbidity in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef less than or equal to 30% or lvef less than or equal to 35% in addition to qrs duration of greater than 130 msec), in addition to standard optimal therapy (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - eplerenone -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - eplerenone, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; iron oxide yellow; sodium lauryl sulfate; polysorbate 80; macrogol 400; purified talc; croscarmellose sodium; titanium dioxide; iron oxide red; hypromellose; magnesium stearate - eplerenone is indicated: - to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3-14 days of an acute myocardial infarction (see clinical trials and dosage and administration). ; - to reduce the risk of cardiovascular mortality and morbidity in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef less than or equal to 30% or lvef less than or equal to 35% in addition to qrs duration of greater than 130 msec), in addition to standard optimal therapy (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - eplerenone, quantity: 50 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; lactose monohydrate; croscarmellose sodium; hypromellose; polysorbate 80; iron oxide yellow; magnesium stearate; iron oxide red; microcrystalline cellulose; macrogol 400; purified talc; titanium dioxide - eplerenone is indicated: - to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3-14 days of an acute myocardial infarction (see clinical trials and dosage and administration). ; - to reduce the risk of cardiovascular mortality and morbidity in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef less than or equal to 30% or lvef less than or equal to 35% in addition to qrs duration of greater than 130 msec), in addition to standard optimal therapy (see clinical trials).

Canada - English - Health Canada

bgp pharma ulc - eplerenone - tablet - 25mg - eplerenone 25mg - mineralocorticoid (aldosterone) receptor antagonists

Canada - English - Health Canada

bgp pharma ulc - eplerenone - tablet - 50mg - eplerenone 50mg - mineralocorticoid (aldosterone) receptor antagonists

Canada - English - Health Canada

genmed a division of pfizer canada ulc - eplerenone - tablet - 25mg - eplerenone 25mg - mineralocorticoid (aldosterone) receptor antagonists

Canada - English - Health Canada

genmed a division of pfizer canada ulc - eplerenone - tablet - 50mg - eplerenone 50mg - mineralocorticoid (aldosterone) receptor antagonists

Canada - English - Health Canada

apotex inc - eplerenone - tablet - 25mg - eplerenone 25mg - mineralocorticoid (aldosterone) receptor antagonists

Canada - English - Health Canada

apotex inc - eplerenone - tablet - 50mg - eplerenone 50mg - mineralocorticoid (aldosterone) receptor antagonists